Cancer Patients Use New Guided Imagery CD to Help Boost Healthy Immune Functioning
...en steadily gaining in popularity and mainstream distribution by hospitals, pharmas
and insurance companies, as new research demonstrates its efficacy for prod...o, Columbia Presbyterian, the Cleveland Clinic and Bethesda Naval Hospital. pharmas
such as Roche, Glaxo Smithkline and Ortho Biotech have distributed over hal...
goBalto Partners With ChinaBio to Expand Its List of Contract Research Organizations
...e happy to be part of their long term strategy," stated Greg Scott, founder and CEO of ChinaBio. "Through our consulting practice, we work with major pharmas
and other companies to identify CROs and CMOs in China that meet their specific needs, and then monitor the projects to help ensure high quality deliv...
Pharmaceutical Product Commercialization & Governance Best Practices: Securing Talent for Highly-Effective Brand Teams
...eb. 7 /PRNewswire/ -- Selecting and deploying
cross- functional, yet sufficiently specialized, brand teams is a new
challenge for marketing leaders at pharmas
and biotechs. However,
best-in-class pharma and biotech firms' brand teams share similar
structure, composition, and responsibilities -- all detailed ...
Gilead's AIDS Drug Awaits Patent in India
...Viread, is hoping to get a patent in India soon.
"We have made considerable progress in implementing our access programme and licensed Indian pharmas
to manufacture Viread which originally announced a pricing of $1 a day for the pill," Gregg Alton, senior vice president and general counsel, Gilead S...
The Industry Impact of Two Big Pharmas Mating
CHICAGO Early this year, the ongoing saga of the consolidating pharmaceutical industry began. For those of you who havent been following the news over the last two weeks, were talking about the hostile bid by French pharmaceutical giant Sanofi-Synthelabo to take over French-German pharmaceutical...
Top 20 big pharmas represent majority of world pharma market
In last weeks column, we explored the world pharmaceutical market, the leading therapeutic classes of drugs and the drug blockbusters, super blockbusters and mega blockbusters.
Though the number of drug blockbusters is on the rise as key Big Pharma companies increasingly globalize their produc...
Eyeforpharma's Marketing Summit is shaping up to be the biggest event of its kind ever
...they have primary and secondary stakeholders, depending on the therapy area, product lifecycle or other factors, he suggests.
With a wider audience, pharmas
will need to focus, prioritize and better target their messages, Awopetu says. “We have to cover a lot more with less, so our messages must be b...
Three Steps to Boost Asymchem's Investment in China
...crease our capacity in the production
of pharmaceutical intermediates and drug substances and will build
ourselves to a one-stop shop to international pharmas
by means of
combination of CMO and CRO,'' stated Dr. Hao Hong, Chairman & CEO of
Asymchem. The operation of new cGMP production facility and R&D cente...
The Generic Drug Industry in Illinois
...nvestors see the potential growth of the U.S. generic drugs business and are ramping up activities to prepare for the opportunities presented when Big pharmas
patents expire. Once a drug loses its patent, sales of the original brand-name product can fall by as much as 70 percent in a matter of a few weeks. ...
Biotech Family Reunion Meets in Illinois
The industry also sported a market cap of $258 billion, which isnt too far from the combined value of Pfizer and Merck (Big pharmas
largest companies). He also stated that the biotech industry has 130 drugs on the market and 350 drugs either awaiting FDA approval or in human clinic...
Midwest Investment Bank Piper Jaffray Resurges in New York City
... nutritional business.
Unfortunately, the story spin was far too detailed and didnt present the excitement of whats to come in the future.
story was very much to the point and exciting. You can see why this companys stock has gone from a low of $6 a share a year ago to more than $40 a sha...
Americas Third Coast nurtures biotechnology
...im Harris, senior director of North American sales operations.
Core customers range from life science researchers in academic settings to those in pharmas
and biotechs developing new drugs. The companys flagship pET system allows researchers to express a wide variety of proteins in bacterial cells in ord...
Biotech IPOs bring in encouraging sums
...ric of the entire worth of the U.S. biotech industry being less than the value of Merck is not only not true, it now takes more than the top two Big pharmas
Pfizer and Merck to match up with the entire U.S. biotech industry, which is $339 billion versus $344 billion.
I am willing to bet with the slow...
Life-science research plan is about more than stem cells
... the year before.
Barrons magazine has predicted larger profit margins in the biotech sector than in traditional pharmaceuticals, due mainly to Big pharmas
struggles with safety concerns, patent expirations and slow R&D timelines.
Given those trends, Wisconsin is wise to hedge its bets and pursue resea...